Results 1 to 10 of about 68,018 (206)

Acknowledgement to Reviewers of Vaccines in 2014

open access: yesVaccines, 2015
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Vaccines Editorial Office
doaj   +1 more source

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen

open access: yesnpj Vaccines, 2023
Seasonal influenza vaccines must be updated annually and suboptimally protect against strains mismatched to the selected vaccine strains. We previously developed a subunit vaccine antigen consisting of a stabilized trimeric influenza A group 1 ...
Maarten Swart   +21 more
doaj   +1 more source

Acknowledgement to Reviewers of Vaccines in 2016

open access: yesVaccines, 2017
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Vaccines Editorial Office
doaj   +1 more source

Acknowledgement to Reviewers of Vaccines in 2018

open access: yesVaccines, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing. [...]
Vaccines Editorial Office
doaj   +1 more source

Acknowledgement to Reviewers of Vaccines in 2015

open access: yesVaccines, 2016
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Vaccines Editorial Office
doaj   +1 more source

Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2

open access: yesnpj Vaccines, 2023
Since the original outbreak of the SARS-CoV-2 virus, several rapidly spreading SARS-CoV-2 variants of concern (VOC) have emerged. Here, we show that a single dose of Ad26.COV2.S (based on the Wuhan-Hu-1 spike variant) protects against the Gamma and Delta
Maarten Swart   +32 more
doaj   +1 more source

Vaccines, Vaccination, and Vaccinology [PDF]

open access: yesThe Journal of Infectious Diseases, 2003
Although the demonstration in 1796 by Edward Jenner that vaccinia virus could protect against smallpox was epochal, he was following the path opened by the ancients who had used the smallpox virus itself in the practice of variolation. The work of Louis Pasteur on chicken cholera opened the way to vaccine development in the laboratory.
openaire   +2 more sources

Acknowledgement to Reviewers of Vaccines in 2013

open access: yesVaccines, 2014
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Vaccines Editorial Office
doaj   +1 more source

Acknowledgement to Reviewers of Vaccines in 2017

open access: yesVaccines, 2018
Peer review is an essential part in the publication process, ensuring that Vaccines maintains high quality standards for its published papers.[...]
Vaccines Editorial Office
doaj   +1 more source

Causal inference concepts applied to three observational studies in the context of vaccine development: from theory to practice

open access: yesBMC Medical Research Methodology, 2021
Background Randomized controlled trials are considered the gold standard to evaluate causal associations, whereas assessing causality in observational studies is challenging.
Emilia Gvozdenović   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy